These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 34680938)
1. Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis. Motwani J; Eccles MR Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680938 [TBL] [Abstract][Full Text] [Related]
2. Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells. Peretz Y; Wu H; Patel S; Bellacosa A; Katz RA PLoS One; 2015; 10(2):e0116839. PubMed ID: 25642713 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression. Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354 [TBL] [Abstract][Full Text] [Related]
4. The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines. Kovacs D; Migliano E; Muscardin L; Silipo V; Catricalà C; Picardo M; Bellei B Oncotarget; 2016 Jul; 7(28):43295-43314. PubMed ID: 27175588 [TBL] [Abstract][Full Text] [Related]
5. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555 [TBL] [Abstract][Full Text] [Related]
6. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF. Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061 [TBL] [Abstract][Full Text] [Related]
7. Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma. Fattore L; Ruggiero CF; Liguoro D; Mancini R; Ciliberto G Cell Death Dis; 2019 Oct; 10(11):827. PubMed ID: 31672982 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation in human melanoma: past and future. Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943 [TBL] [Abstract][Full Text] [Related]
9. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis. Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneous tumor subpopulations cooperate to drive invasion. Chapman A; Fernandez del Ama L; Ferguson J; Kamarashev J; Wellbrock C; Hurlstone A Cell Rep; 2014 Aug; 8(3):688-95. PubMed ID: 25066122 [TBL] [Abstract][Full Text] [Related]
11. BRN2, a POUerful driver of melanoma phenotype switching and metastasis. Fane ME; Chhabra Y; Smith AG; Sturm RA Pigment Cell Melanoma Res; 2019 Jan; 32(1):9-24. PubMed ID: 29781575 [TBL] [Abstract][Full Text] [Related]
12. Making a melanoma: Molecular and cellular changes underlying melanoma initiation. Darp R; Ceol C Pigment Cell Melanoma Res; 2021 Mar; 34(2):280-287. PubMed ID: 33283422 [TBL] [Abstract][Full Text] [Related]
13. Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives. Marzese DM; Witz IP; Kelly DF; Hoon DS Epigenomics; 2015; 7(8):1303-11. PubMed ID: 26638944 [TBL] [Abstract][Full Text] [Related]